CLINICAL_TRIALS
trial_result
· 2025-11-12
Clinical Trial Update: A Study of Imlunestrant (LY3484356) in Female Participants With Impaired Liver Function [Phase 1]
Summary
Phase 1 study evaluating Imlunestrant (LY3484356) in female participants with hepatic insufficiency, with results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Hepatic Insufficiency, Healthy | Phase 1 | Status: COMPLETED | Results posted: 2025-11-12